Pfizer Covid-19 shot 91pct effective in updated data, protective against S African variant


Modified 2 Apr 2021, 1:34 am

Pfizer Inc and BioNTech's Covid-19 vaccine is around 91 percent effective in preventing the disease, they said on Thursday, citing updated trial data that included participants inoculated for up to six months.

The shot was also 100 percent effective in preventing illness among trial participants in South Africa, where a new variant called B1351 is dominant, though the number of those participants was relatively small at 800...

All Access Plan
starting from


per month
Subscribe Now
You can cancel anytime.
Get unlimited access to our articles on web and apps
Add comments to our articles
Bookmark articles to read later
We accept
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In